Total Valuation
Tandem Diabetes Care has a market cap or net worth of $1.58B. The enterprise value is $1.32K.
Market Cap$1.58B
Enterprise Value$1.32K
Share Statistics
Tandem Diabetes Care has 69,578,705 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding69,578,705
Owned by Insiders0.98%
Owned by Institutions42.72%
Financial Efficiency
Tandem Diabetes Care’s return on equity (ROE) is -1.32 and return on invested capital (ROIC) is -11.88%.
Return on Equity (ROE)-1.32
Return on Assets (ROA)-0.23
Return on Invested Capital (ROIC)-11.88%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee405.89K
Profits Per Employee-81.88K
Employee Count2,500
Asset Turnover1.15
Inventory Turnover3.76
Valuation Ratios
The current PE Ratio of Tandem Diabetes Care is ―. Tandem Diabetes Care’s PEG ratio is -0.07.
PE Ratio―
PS Ratio1.46
PB Ratio9.53
Price to Fair Value9.53
Price to FCF-49.85
Price to Operating Cash Flow-281.31
PEG Ratio-0.07
Income Statement
In the last 12 months, Tandem Diabetes Care had revenue of 1.01B and earned -204.71M in profits. Earnings per share was -3.04.
Revenue1.01B
Gross Profit530.85M
Operating Income-78.12M
Pretax Income-200.27M
Net Income-204.71M
EBITDA-174.70M
Earnings Per Share (EPS)-3.04
Cash Flow
In the last 12 months, operating cash flow was -5.52M and capital expenditures -21.09M, giving a free cash flow of -26.62M billion.
Operating Cash Flow-5.52M
Free Cash Flow-26.62M
Free Cash Flow per Share-0.38
Dividends & Yields
Tandem Diabetes Care pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.35
52-Week Price Change101.68%
50-Day Moving Average17.30
200-Day Moving Average19.34
Relative Strength Index (RSI)73.36
Average Volume (3m)604.00
Important Dates
Tandem Diabetes Care upcoming earnings date is Nov 4, 2026, After Close (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateNov 4, 2026
Ex-Dividend Date―
Financial Position
Tandem Diabetes Care as a current ratio of 2.55, with Debt / Equity ratio of 566.96%
Current Ratio2.55
Quick Ratio2.02
Debt to Market Cap0.21
Net Debt to EBITDA-2.03
Interest Coverage Ratio-9.88
Taxes
In the past 12 months, Tandem Diabetes Care has paid 4.44M in taxes.
Income Tax4.44M
Effective Tax Rate-0.02
Enterprise Valuation
Tandem Diabetes Care EV to EBITDA ratio is -10.49, with an EV/FCF ratio of -61.77.
EV to Sales1.81
EV to EBITDA-10.49
EV to Free Cash Flow-61.77
EV to Operating Cash Flow-188.54
Balance Sheet
Tandem Diabetes Care has $456.00M in cash and marketable securities with $739.25M in debt, giving a net cash position of -$283.26M billion.
Cash & Marketable Securities$456.00M
Total Debt$739.25M
Net Cash-$283.26M
Net Cash Per Share-$4.07
Tangible Book Value Per Share$2.31
Margins
Gross margin is 56.01%, with operating margin of -7.70%, and net profit margin of -20.17%.
Gross Margin56.01%
Operating Margin-7.70%
Pretax Margin-19.74%
Net Profit Margin-20.17%
EBITDA Margin-17.22%
EBIT Margin-18.96%
Analyst Forecast
The average price target for Tandem Diabetes Care is $26.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$26.50
Price Target Upside59.16% Upside
Analyst ConsensusModerate Buy
Analyst Count15
Revenue Growth Forecast3.92%
EPS Growth Forecast70.03%